Matches in SemOpenAlex for { <https://semopenalex.org/work/W188051788> ?p ?o ?g. }
- W188051788 endingPage "53" @default.
- W188051788 startingPage "235" @default.
- W188051788 abstract "The BRAVISSIMO study is a prospective, non-randomized, multi-center, multi-national, monitored trial, conducted at 12 hospitals in Belgium and 11 hospitals in Italy. This manuscript reports the findings up to the 12-month follow-up time point for both the TASC A&B cohort and the TASC C&D cohort. The primary endpoint of the study is primary patency at 12 months, defined as a target lesion without a hemodynamically significant stenosis on Duplex ultrasound (>50%, systolic velocity ratio no greater than 2.0) and without target lesion revascularization (TLR) within 12 months. Between July 2009 and September 2010, 190 patients with TASC A or TASC B aortoiliac lesions and 135 patients with TASC C or TASC D aortoiliac lesions were included. The demographic data were comparable for the TASC A/B cohort and the TASC C/D cohort. The number of claudicants was significantly higher in the TASC A/B cohort, The TASC C/D cohort contains more CLI patients. The primary patency rate for the total patient population was 93.1%. The primary patency rates at 12 months for the TASC A, B, C and D lesions were 94.0%, 96.5%, 91.3% and 90.2% respectively. No statistical significant difference was shown when comparing these groups. Our findings confirm that endovascular therapy, and more specifically primary stenting, is the preferred treatment for patients with TASC A, B, C and D aortoiliac lesions. We notice similar endovascular results compared to surgery, however without the invasive character of surgery." @default.
- W188051788 created "2016-06-24" @default.
- W188051788 creator A5001614017 @default.
- W188051788 creator A5001840951 @default.
- W188051788 creator A5003774188 @default.
- W188051788 creator A5006537028 @default.
- W188051788 creator A5007945989 @default.
- W188051788 creator A5009058632 @default.
- W188051788 creator A5009544053 @default.
- W188051788 creator A5011302671 @default.
- W188051788 creator A5013673331 @default.
- W188051788 creator A5013908509 @default.
- W188051788 creator A5015121795 @default.
- W188051788 creator A5015471623 @default.
- W188051788 creator A5017330920 @default.
- W188051788 creator A5018501927 @default.
- W188051788 creator A5019388263 @default.
- W188051788 creator A5020424654 @default.
- W188051788 creator A5021301102 @default.
- W188051788 creator A5027109990 @default.
- W188051788 creator A5028263534 @default.
- W188051788 creator A5034132546 @default.
- W188051788 creator A5035168236 @default.
- W188051788 creator A5038012814 @default.
- W188051788 creator A5038313087 @default.
- W188051788 creator A5043391788 @default.
- W188051788 creator A5043700021 @default.
- W188051788 creator A5043788463 @default.
- W188051788 creator A5044053239 @default.
- W188051788 creator A5045173534 @default.
- W188051788 creator A5046208668 @default.
- W188051788 creator A5047473208 @default.
- W188051788 creator A5050669429 @default.
- W188051788 creator A5050957330 @default.
- W188051788 creator A5051313912 @default.
- W188051788 creator A5051346274 @default.
- W188051788 creator A5054780838 @default.
- W188051788 creator A5054937833 @default.
- W188051788 creator A5057279603 @default.
- W188051788 creator A5059285392 @default.
- W188051788 creator A5062240943 @default.
- W188051788 creator A5065944185 @default.
- W188051788 creator A5068820581 @default.
- W188051788 creator A5070445547 @default.
- W188051788 creator A5072605763 @default.
- W188051788 creator A5073076864 @default.
- W188051788 creator A5074906609 @default.
- W188051788 creator A5077049930 @default.
- W188051788 creator A5077284486 @default.
- W188051788 creator A5081467335 @default.
- W188051788 creator A5081797241 @default.
- W188051788 creator A5082519731 @default.
- W188051788 creator A5082874153 @default.
- W188051788 creator A5083283183 @default.
- W188051788 creator A5086687189 @default.
- W188051788 creator A5087175493 @default.
- W188051788 creator A5087812735 @default.
- W188051788 creator A5088974941 @default.
- W188051788 creator A5089155680 @default.
- W188051788 date "2013-04-01" @default.
- W188051788 modified "2023-10-05" @default.
- W188051788 title "BRAVISSIMO: 12-month results from a large scale prospective trial." @default.
- W188051788 cites W1979222591 @default.
- W188051788 cites W2020577516 @default.
- W188051788 cites W2031466108 @default.
- W188051788 cites W2066839339 @default.
- W188051788 cites W2091571680 @default.
- W188051788 cites W2106461476 @default.
- W188051788 cites W2144985796 @default.
- W188051788 cites W2161900214 @default.
- W188051788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23558659" @default.
- W188051788 hasPublicationYear "2013" @default.
- W188051788 type Work @default.
- W188051788 sameAs 188051788 @default.
- W188051788 citedByCount "7" @default.
- W188051788 countsByYear W1880517882014 @default.
- W188051788 countsByYear W1880517882016 @default.
- W188051788 countsByYear W1880517882018 @default.
- W188051788 countsByYear W1880517882019 @default.
- W188051788 countsByYear W1880517882021 @default.
- W188051788 crossrefType "journal-article" @default.
- W188051788 hasAuthorship W188051788A5001614017 @default.
- W188051788 hasAuthorship W188051788A5001840951 @default.
- W188051788 hasAuthorship W188051788A5003774188 @default.
- W188051788 hasAuthorship W188051788A5006537028 @default.
- W188051788 hasAuthorship W188051788A5007945989 @default.
- W188051788 hasAuthorship W188051788A5009058632 @default.
- W188051788 hasAuthorship W188051788A5009544053 @default.
- W188051788 hasAuthorship W188051788A5011302671 @default.
- W188051788 hasAuthorship W188051788A5013673331 @default.
- W188051788 hasAuthorship W188051788A5013908509 @default.
- W188051788 hasAuthorship W188051788A5015121795 @default.
- W188051788 hasAuthorship W188051788A5015471623 @default.
- W188051788 hasAuthorship W188051788A5017330920 @default.
- W188051788 hasAuthorship W188051788A5018501927 @default.
- W188051788 hasAuthorship W188051788A5019388263 @default.
- W188051788 hasAuthorship W188051788A5020424654 @default.
- W188051788 hasAuthorship W188051788A5021301102 @default.